SCYX: SCYNEXIS Inc. Stocks News on July 27, 2024

SCYNEXIS to Receive $10 Million Milestone Payment from GSK Triggered by Delivery of Completed FURI, CARES and NATURE Clinical Study Reports

SCYX

GlobeNewswire

4 days ago

SCYNEXIS to Receive $10 Million Milestone Payment from GSK Triggered by Delivery of Completed FURI, CARES and NATURE Clinical Study Reports

SCYX

Associated Press Finance

3 months ago

Scynexis: Q1 Earnings Snapshot

SCYNEXIS Reports First Quarter 2024 Financial Results and Provides Corporate Update

SCYX

GlobeNewswire

3 months ago

SCYNEXIS Reports First Quarter 2024 Financial Results and Provides Corporate Update

SCYX

Simply Wall St.

3 months ago

Investors in SCYNEXIS (NASDAQ:SCYX) have unfortunately lost 87% over the last five years

SCYNEXIS Presented Preclinical Data on Second Generation Fungerp SCY-247 at the Congress of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID Global, Formerly ECCMID)

SCYX

GlobeNewswire

3 months ago

SCYNEXIS Presented Preclinical Data on Second Generation Fungerp SCY-247 at the Congress of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID Global, Formerly ECCMID)

SCYNEXIS to Present Preclinical Data on Second Generation Fungerp SCY-247 at the 34th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)

SCYX

GlobeNewswire

4 months ago

SCYNEXIS to Present Preclinical Data on Second Generation Fungerp SCY-247 at the 34th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)

SCYNEXIS Reports Full Year 2023 Financial Results and Provides Corporate Update

SCYX

GlobeNewswire

4 months ago

SCYNEXIS Reports Full Year 2023 Financial Results and Provides Corporate Update

SCYNEXIS to Participate in Guggenheim’s 6th Annual Biotechnology Conference

SCYX

GlobeNewswire

6 months ago

SCYNEXIS to Participate in Guggenheim’s 6th Annual Biotechnology Conference

SCYNEXIS Presented Preclinical Data on Second Generation Fungerp SCY-247 against Mucormycosis at the 11th Advances Against Aspergillosis and Mucormycosis Conference

SCYX

GlobeNewswire

6 months ago

SCYNEXIS Presented Preclinical Data on Second Generation Fungerp SCY-247 against Mucormycosis at the 11th Advances Against Aspergillosis and Mucormycosis Conference

SCYX

GuruFocus.com

6 months ago

MetroCity Bankshares Inc Reports Mixed Results for Q4 and Full Year 2023

SCYX

Associated Press Finance

6 months ago

MetroCity: Q4 Earnings Snapshot

METROCITY BANKSHARES, INC. REPORTS EARNINGS FOR FOURTH QUARTER AND YEAR ENDED 2023

SCYX

PR Newswire

6 months ago

METROCITY BANKSHARES, INC. REPORTS EARNINGS FOR FOURTH QUARTER AND YEAR ENDED 2023

Mama’s Creations to Ring Nasdaq Closing Bell on Tuesday, January 23, 2024

SCYX

GlobeNewswire

6 months ago

Mama’s Creations to Ring Nasdaq Closing Bell on Tuesday, January 23, 2024

New research warns of emerging "AI Gap" between brands and consumers

SCYX

PR Newswire

6 months ago

New research warns of emerging "AI Gap" between brands and consumers

OFS Credit Company Provides December 2023 Net Asset Value Update

SCYX

Business Wire

6 months ago

OFS Credit Company Provides December 2023 Net Asset Value Update

Oil Prices Weighed Down by Massive Build in Fuel Inventories

SCYX

Zacks

7 months ago

Oil Prices Weighed Down by Massive Build in Fuel Inventories

SCYNEXIS to Present Preclinical Data on Second Generation Fungerp SCY-247 at the 11th Advances Against Aspergillosis and Mucormycosis Conference, January 25 – 27, in Milan, Italy

SCYX

GlobeNewswire

7 months ago

SCYNEXIS to Present Preclinical Data on Second Generation Fungerp SCY-247 at the 11th Advances Against Aspergillosis and Mucormycosis Conference, January 25 – 27, in Milan, Italy

PLBY Group to Participate in the 2024 ICR Conference

SCYX

GlobeNewswire

7 months ago

PLBY Group to Participate in the 2024 ICR Conference

Electrovaya Begins Shipping Infinity-HV Battery Systems

SCYX

ACCESSWIRE

7 months ago

Electrovaya Begins Shipping Infinity-HV Battery Systems

Brightcove Appoints New CMO and CRO, Creates COO Position

SCYX

Business Wire

7 months ago

Brightcove Appoints New CMO and CRO, Creates COO Position

FVCBankcorp (FVCB) Soars 5.9%: Is Further Upside Left in the Stock?

SCYX

Zacks

7 months ago

FVCBankcorp (FVCB) Soars 5.9%: Is Further Upside Left in the Stock?

Syntec Optics Expands Thin-Film Technology with Gold Coating Capabilities (Nasdaq: OPTX)

SCYX

GlobeNewswire

8 months ago

Syntec Optics Expands Thin-Film Technology with Gold Coating Capabilities (Nasdaq: OPTX)

SCYX

Simply Wall St.

8 months ago

Shareholders in SCYNEXIS (NASDAQ:SCYX) are in the red if they invested five years ago

SCYX

Insider Monkey

8 months ago

11 Cheapest Stocks With Biggest Upside

Unlocking Financial Freedom: The Power of Flex CDs in Today's Economy

SCYX

PR Newswire

8 months ago

Unlocking Financial Freedom: The Power of Flex CDs in Today's Economy

5 Struggling Stocks to Buy at a Discount

SCYX

Motley Fool

8 months ago

5 Struggling Stocks to Buy at a Discount

SCYX

Associated Press Finance

8 months ago

Scynexis: Q3 Earnings Snapshot

SCYNEXIS Reports Third Quarter 2023 Financial Results and Provides Corporate Update

SCYX

GlobeNewswire

8 months ago

SCYNEXIS Reports Third Quarter 2023 Financial Results and Provides Corporate Update

Ocugen, Inc. Announces First Patient Dosed in Phase 1/2 Clinical Trial Evaluating the Safety and Efficacy of OCU410ST—Modifier Gene Therapy—for Stargardt Disease

SCYX

GlobeNewswire

9 months ago

Ocugen, Inc. Announces First Patient Dosed in Phase 1/2 Clinical Trial Evaluating the Safety and Efficacy of OCU410ST—Modifier Gene Therapy—for Stargardt Disease

CORRECTING AND REPLACING: NOVONIX Finalizes US$100 Million Grant Award from U.S. Department of Energy

SCYX

GlobeNewswire

9 months ago

CORRECTING AND REPLACING: NOVONIX Finalizes US$100 Million Grant Award from U.S. Department of Energy

Positive Signs As Multiple Insiders Buy Relmada Therapeutics Stock

SCYX

Simply Wall St.

9 months ago

Latest SCYNEXIS Inc. (SCYX) News on July 27, 2024

SCYNEXIS to Receive $10 Million Milestone Payment from GSK Triggered by Delivery of Completed FURI, CARES and NATURE Clinical Study Reports

Scynexis: Q1 Earnings Snapshot

SCYNEXIS Reports First Quarter 2024 Financial Results and Provides Corporate Update

Investors in SCYNEXIS (NASDAQ:SCYX) have unfortunately lost 87% over the last five years

SCYNEXIS Presented Preclinical Data on Second Generation Fungerp SCY-247 at the Congress of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID Global, Formerly ECCMID)

SCYNEXIS to Present Preclinical Data on Second Generation Fungerp SCY-247 at the 34th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)

SCYNEXIS Reports Full Year 2023 Financial Results and Provides Corporate Update

SCYNEXIS to Participate in Guggenheim’s 6th Annual Biotechnology Conference

SCYNEXIS Presented Preclinical Data on Second Generation Fungerp SCY-247 against Mucormycosis at the 11th Advances Against Aspergillosis and Mucormycosis Conference

MetroCity Bankshares Inc Reports Mixed Results for Q4 and Full Year 2023

MetroCity: Q4 Earnings Snapshot

METROCITY BANKSHARES, INC. REPORTS EARNINGS FOR FOURTH QUARTER AND YEAR ENDED 2023

Mama’s Creations to Ring Nasdaq Closing Bell on Tuesday, January 23, 2024

New research warns of emerging "AI Gap" between brands and consumers

OFS Credit Company Provides December 2023 Net Asset Value Update

Oil Prices Weighed Down by Massive Build in Fuel Inventories

SCYNEXIS to Present Preclinical Data on Second Generation Fungerp SCY-247 at the 11th Advances Against Aspergillosis and Mucormycosis Conference, January 25 – 27, in Milan, Italy

PLBY Group to Participate in the 2024 ICR Conference

Electrovaya Begins Shipping Infinity-HV Battery Systems

Brightcove Appoints New CMO and CRO, Creates COO Position

FVCBankcorp (FVCB) Soars 5.9%: Is Further Upside Left in the Stock?

Syntec Optics Expands Thin-Film Technology with Gold Coating Capabilities (Nasdaq: OPTX)

Shareholders in SCYNEXIS (NASDAQ:SCYX) are in the red if they invested five years ago

11 Cheapest Stocks With Biggest Upside

Unlocking Financial Freedom: The Power of Flex CDs in Today's Economy

5 Struggling Stocks to Buy at a Discount

Scynexis: Q3 Earnings Snapshot

SCYNEXIS Reports Third Quarter 2023 Financial Results and Provides Corporate Update

Ocugen, Inc. Announces First Patient Dosed in Phase 1/2 Clinical Trial Evaluating the Safety and Efficacy of OCU410ST—Modifier Gene Therapy—for Stargardt Disease

CORRECTING AND REPLACING: NOVONIX Finalizes US$100 Million Grant Award from U.S. Department of Energy

Positive Signs As Multiple Insiders Buy Relmada Therapeutics Stock

Share on Social Networks: